Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008.
- Author:
Hyeon Jin PARK
1
;
Eun Hye PARK
;
Kyu Won JUNG
;
Hyun Joo KONG
;
Young Joo WON
;
Joo Young LEE
;
Jong Hyung YOON
;
Byung Kiu PARK
;
Hyewon LEE
;
Hyeon Seok EOM
;
Sohee PARK
Author Information
- Publication Type:Original Article
- Keywords: Hematologic malignancy; Incidence; Survival; Prevalence; Korea
- MeSH: Hematologic Neoplasms; Hematology; Humans; Incidence; Korea; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Multiple Myeloma; Prevalence; Survival Rate
- From:Korean Journal of Hematology 2012;47(1):28-38
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: The nationwide statistical analysis of hematologic malignancies in Korea has not been reported yet. METHODS: The Korea Central Cancer Registry and the Korean Society of Hematology jointly investigated domestic incidence rates and prevalence of hematologic malignancies occurred between 1999 and 2008, and analyzed survival rates of patients who were diagnosed between 1993 and 2008. Data of hematologic malignancies from 1993 to 2008 were obtained from the Korean National Cancer Incidence Data base. The crude incidence rates, age-specific incidence rates, age-standardized incidence rates, annual percentage change of incidence, and prevalence from 1999-2008 were calculated. Survival rates for patients diagnosed in 1993-2008 were estimated. RESULTS: In 2008, a total of 8,006 cases of hematologic malignancies were occurred, which comprised 4.5% of all malignancies. In all genders, non-Hodgkin lymphoma, myeloid leukemia, and multiple myeloma were most frequent diseases. In terms of age, ages between 60 and 69 were most prevalent. From 1999 to 2008, the age-standardized incidence rates increased from 10.2 to 13.7, and the annual percentage change was 3.9%. The 5-year survival rate increased from 38.2% during 1993-1995 to 55.2% during 2004-2008. As of January 2009, number of patients with 10-year prevalence was 33,130, and with 5- to 10-year prevalence was 10,515. CONCLUSION: This is the first nationwide statistical report of hematologic malignancies in Korea. It could be used as the basic information to help investigate epidemiologic characteristics, evaluate progress during the past years, and establish future strategies for hematologic malignancies. Periodic statistical analysis of hematologic malignancies in Korea should be continued.
